Orthofix Medical develops and sells orthopedic and spine medical devices used by surgeons to treat bone and soft-tissue conditions. Its portfolio includes spinal fixation systems, bone growth stimulation products and solutions for fracture repair and deformity correction. Customers are primarily hospitals, surgery centers and orthopedic specialists seeking implants and enabling technologies for musculoskeletal care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 193.7 | — | -53.1 | — |
| Q2 2025 | 203.1 | — | -14.1 | — |
| Q3 2025 | 205.6 | — | -22.8 | — |
| Q4 2025 | 219.9 | — | -2.2 | — |
| Q1 2026 | 196.7 | 1.6% | -20.9 | — |
| Q2 2026 | 210.9 | 3.9% | -15.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Lesaka Technologies, Inc. (LSAK), Keystone Acquisition Corp. (KEYY), Myriad Genetics, Inc. (MYGN), Parke Bancorp, Inc. (PKBK), Northeast Community Bancorp, Inc. (NECB), Scribe Therapeutics Inc. (SCTX)